Cargando…
Optimization of Tyrosine Kinase Inhibitor-Loaded Gold Nanoparticles for Stimuli-Triggered Antileukemic Drug Release
Tyrosine kinase inhibitor (TKI) therapy is gaining attraction in advanced cancer therapeutics due to the ubiquity of kinases in cell survival and differentiation. Great progress was made in the past years in identifying tyrosine kinases that can function as valuable molecular targets and for the ent...
Autores principales: | Tatar, Andra-Sorina, Nagy-Simon, Timea, Tigu, Adrian Bogdan, Tomuleasa, Ciprian, Boca, Sanda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10455807/ https://www.ncbi.nlm.nih.gov/pubmed/37623644 http://dx.doi.org/10.3390/jfb14080399 |
Ejemplares similares
-
Design of FLT3 Inhibitor - Gold Nanoparticle Conjugates as Potential Therapeutic Agents for the Treatment of Acute Myeloid Leukemia
por: Simon, Timea, et al.
Publicado: (2015) -
Gold nanoparticles enhance the effect of tyrosine kinase inhibitors in acute myeloid leukemia therapy
por: Petrushev, Bobe, et al.
Publicado: (2016) -
Outcomes of CAR-T Cell Therapy Recipients Admitted to the ICU: In Search for a Standard of Care—A Brief Overview and Meta-Analysis of Proportions
por: Constantinescu, Catalin, et al.
Publicado: (2023) -
In vivo assessment of bone marrow toxicity by gold nanoparticle-based bioconjugates in Crl:CD1(ICR) mice
por: Berce, Cristian, et al.
Publicado: (2016) -
Cisplatin-loaded hollow gold nanoparticles for laser-triggered release
por: Xiong, Chiyi, et al.
Publicado: (2018)